Tigecine: Dosages and Ingredients | Full Prescribing Info

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contents

Tigecycline.

Description

Each vial contains: Tigecycline 50 mg.

Indications/Uses

Complicated intra-abdominal, skin and skin structure infections.

Dosage/Direction for Use

Initially 100 mg followed by 50 mg every 12 hours. Administer through intravenous infusion over approximately 30 to 60 minutes.
Duration of treatment: 5 to 14 days.

Contraindications

Hypersensitivity.

Special Precautions

Caution when used for monotherapy in patients with complicated intra-abdominal infections secondary to clinically apparent intestinal perforation, with known hypersensitivity to tetracycline. Consider pseudomembranous colitis in patients with diarrhea. Carefully monitor patients during therapy to prevent superinfections. Monitor patients with severe hepatic impairment. May impair ability to drive or operate machinery. Pregnancy and lactation. Children less than 18 years old.

Adverse Reactions

Nausea, vomiting, diarrhea, anorexia, abdominal pain, dyspepsia, pruritus, rash, headache, dizziness, phlebitis, thrombophlebitis. Prolonged prothrombin time, bilirubinemia, increased blood urea nitrogen.

View ADR Reporting Link

MIMS Class

Tetracyclines

ATC Classification

J01AA12 - tigecycline ; Belongs to the class of tetracyclines. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Tigecine powd for inj 50 mg

Packing/Price

2 × 1's

Tigecine

tigecycline

Manufacturer:

Fahrenheit